Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea

Allergan

Status: Completed

Conditions: Ocular Hypertension; Glaucoma, Open-Angle

Treatments: Drug: bimatoprost/timolol

Study type: Observational

Funder types: Industry

Identifiers

NCT01976624

192024-087

Details and patient eligibility

About

This study is a Post-Marketing Surveillance study to evaluate the safety and efficacy of bimatoprost/timolol (Ganfort®) Ophthalmic Solution to treat open-angle glaucoma or ocular hypertension in Korea.

Enrollment: 756 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients treated with Ganfort® for open-angle glaucoma or ocular hypertension in clinical practice.

Exclusion criteria

• None.

Trial design

756 participants in 1 patient group

Ganfort®

Description:

Patients who received treatment with bimatoprost/timolol (Ganfort®) for open-angle glaucoma or ocular hypertension as per local standard of care in clinical practice.

Treatment:

Drug: bimatoprost/timolol